SK Biopharm Presents Latest Cenobamate Research Results at American Epilepsy Society Meeting

10 Poster Presentations Conducted
Symposium Held at Conference

SK Biopharm announced on the 29th that, together with its U.S. distribution subsidiary SK Life Sciences, it will present 10 research results along with a symposium at the 2023 American Epilepsy Society (AES) Annual Meeting held in Orlando, Florida, USA, from December 1 to 5 (local time).

SK Biopharm Cenobamate (U.S. product name Xcopri). [Photo by SK Biopharm]

At the symposium hosted by SK Life Sciences on December 2, discussions will be held under the theme "Impact of Continuous Seizures and Strategies for Seizure Reduction/Elimination," focusing on treatment strategies aimed at reducing and eliminating seizures in epilepsy patients and the unmet needs regarding complete seizure freedom.

Presenters at this symposium will include ▲Daniel Becker, Associate Professor of Neurology at Wexner Medical Center, Ohio State University ▲Pavel Klein, Director of the Mid-Atlantic Epilepsy and Sleep Center ▲Gregory Krauss, Professor of Neurology at Johns Hopkins University School of Medicine ▲Patrick Kwan, Professor of the Epilepsy Unit at Monash University Monash Institute of Medical Engineering, Alfred Hospital, Melbourne, Australia.

Additionally, the 10 poster presentations will cover research topics such as ▲monotherapy of the new epilepsy drug cenobamate (U.S. brand name Xcopri) ▲comparative analysis of medical information (hospitalization days, emergency room visits, etc.) to confirm efficacy in refractory pediatric epilepsy ▲long-term (up to 60 months) efficacy analysis of patients participating in clinical (OLE) studies ▲case analyses of dose reductions of concomitant medications when taking cenobamate.

Louis Ferrari, Vice President of Medical Affairs at SK Life Sciences, said, "We expect that the symposium and poster presentations at this AES will provide healthcare providers with the latest important information, including solutions to issues related to drug administration and management, to help them care for patients."

This content was produced with the assistance of AI translation services.